Sanofi

Viehbacher Sees New Sanofi Growing in Diagnostics, Nutrition

Viehbacher Sees New Sanofi Growing in Diagnostics, Nutrition

Bloomberg

Sanofi Misses Earnings But Steps In Right Direction

Sanofi Misses Earnings But Steps In Right Direction

Seeking Alpha

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

Seeking Alpha

Sanofi's New Diabetes Play Moves Forward

Sanofi's New Diabetes Play Moves Forward

Motley Fool

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Seeking Alpha

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Seeking Alpha

SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China

SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China

Yahoo/MarketWire

Eli Lilly May Have The Best Chance At Keeping The Momentum Going

Eli Lilly May Have The Best Chance At Keeping The Momentum Going

Seeking Alpha

What's in Regeneron's Pipes?

What's in Regeneron's Pipes?

Motley Fool

Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013

Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013

Yahoo/AP